This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego

Ian Villamagna, PhD
Senior Field Application Scientist at Precision NanoSystems


Ian Villamagna currently serves as a Senior Field Application Scientist for Precision NanoSystems, covering the Northwestern United States and Western Canada. In his role, he forms active partnerships with customers and works to drive the development of genomic medicines from early preclinical testing through clinical manufacturing. Ian obtained his Ph.D. at the University of Western Ontario, where he was responsible for the development of multiple nanoparticle drug delivery formulations for the treatment of osteoarthritis. He has extensive experience in the nanomedicine development process, from formulation of new materials leading large animal trials. He has a broad educational background, combining training in basic sciences such as biology and chemistry as well as applied sciences such as animal and human physiology and engineering.

Agenda Sessions

  • Scale-Up and Development Considerations to Accelerate mRNA-LNP Vaccine Manufacturing